ELAVL1 and prostate cancer: CircEXOC6B can bind with RBMS1 and HuR and elevate AKAP12 (A-kinase anchoring protein 12) expression levels, leading to inhibition of tumor metastasis in prostate cancer (Zhang et al., 2023b).